Product Name: Exenatide
Form: Acetate salt
CAS No: 141758-74-9
Molar Mass: 4186.57
Chemical Formula: C184H282N50O60S
Synonyms: AC 2993, Bydureon, DA 3091
Storage: Store at -20℃
Sequence: HGEGTFTSDL SKQMEEEAVR LFIEWLKNGG PSSGAPPPS
Target: GLP-1 RA
Application: Exenatide (CAS number 141758-74-9) is a pivotal pharmaceutical compound employed in the treatment of type 2 diabetes, belonging to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Administered via injection, Exenatide mimics endogenous GLP-1, enhancing glucose-dependent insulin secretion and suppressing glucagon release, resulting in improved blood glucose control. This dual mechanism makes it particularly valuable for individuals not achieving sufficient glycemic control with oral antidiabetic medications alone. Beyond its primary role in glycemic management, Exenatide has shown promise in conferring cardiovascular benefits, further enhancing its therapeutic profile. In the pharmaceutical landscape, Exenatide is recognized for its efficacy in improving glucose homeostasis, positioning it as a valuable component in the comprehensive care of patients with type 2 diabetes.
Current Research:
Exenatide is a synthetic GLP-1 receptor agonist approved for the treatment of type 2 diabetes. Unlike dulaglutide, which is designed for weekly administration, exenatide is typically given either twice daily (for the immediate-release formulation) or weekly (for the extended-release version). Exenatide helps regulate blood sugar by mimicking the natural GLP-1 hormone, which plays a role in insulin secretion and glucose metabolism. Its rapid onset and dual action on blood sugar levels and appetite control make it a valuable treatment option for patients with poorly controlled diabetes and those with weight concerns.
Mechanism of Action
Exenatide operates through the activation of GLP-1 receptors, triggering a cascade of effects that enhance insulin secretion in response to meals, inhibit glucagon release, and slow gastric emptying. Its rapid action makes it particularly effective at controlling postprandial blood glucose spikes. In contrast to dulaglutide, which offers a more prolonged effect, exenatide’s quicker onset of action is beneficial for patients needing fast and targeted intervention after meals. Additionally, exenatide reduces appetite, contributing to weight loss by curbing hunger signals.
Cardiovascular Benefits
While both exenatide and dulaglutide have shown benefits for heart health in diabetes patients, exenatide's cardiovascular advantages have been studied in more short-term contexts, focusing on immediate improvements in risk factors like blood pressure and lipid levels. Though not as extensively studied in large-scale cardiovascular outcome trials as dulaglutide, exenatide has been linked to a reduction in the risk of heart-related events, making it an important option for patients with type 2 diabetes at elevated cardiovascular risk. Its cardiovascular impact is mainly through its ability to improve glycemic control and reduce weight, both of which are key to managing heart health in diabetic patients.
Weight Loss and Obesity Management
Exenatide is particularly effective for promoting weight loss in patients with type 2 diabetes, with research showing significant reductions in body weight. The drug helps reduce calorie intake by suppressing appetite and promoting a feeling of fullness, which can lead to more consistent weight management. Unlike dulaglutide, which provides more gradual weight loss over time, exenatide’s action is quicker, leading to more immediate changes in body weight. This makes exenatide a useful option for patients who need to rapidly address obesity or weight gain as part of their diabetes management.
Neuroprotective Potential
Exenatide has recently gained attention for its potential neuroprotective effects, particularly in the context of neurodegenerative diseases like Parkinson's disease. Preliminary studies suggest that exenatide might protect neurons from oxidative damage and improve motor function, offering a new potential application outside of diabetes. Although this area of research is still in its infancy, early findings suggest that exenatide could help mitigate some symptoms of neurodegenerative disorders by improving mitochondrial function and reducing inflammation, offering a promising avenue for future studies.
Safety and Tolerability
Exenatide is generally well tolerated by most patients, though some individuals may experience mild gastrointestinal side effects such as nausea, vomiting, or diarrhea. These symptoms typically occur when treatment is initiated but tend to decrease over time. Since exenatide is administered more frequently than dulaglutide, injection site reactions may be more common, especially with the immediate-release formulation. However, these reactions are generally mild and resolve on their own. As with all GLP-1 receptor agonists, exenatide should be used cautiously in patients with a history of pancreatitis or thyroid issues.
Combination Therapy
Exenatide can be used in combination with other diabetes medications, such as metformin or insulin, to provide enhanced blood glucose control. It has been shown to be particularly effective when combined with oral drugs, providing a multi-pronged approach to managing type 2 diabetes. Although dulaglutide offers the advantage of weekly dosing, exenatide's faster-acting nature and flexible administration schedule make it a good choice for patients needing tighter control over post-meal blood sugar fluctuations.
Get a Quote
LinkPeptide
